<DOC>
	<DOCNO>NCT00519480</DOCNO>
	<brief_summary>This study ass safety tolerability metformin plus GSK189075 people Type 2 Diabetes . About 48 people participate study . Volunteers know receive GSK189075 placebo . Participation last 5 week include run-in period 2 week necessary increase metformin 2000mg daily , 13-day treatment period , follow-up visit 1 week treatment period . Volunteers remain research clinic begin 2 day receive first dose GSK189075 morning dose fourth day afternoon 12th day dose morning last dose . They clinic visit dose Days 6 , 8 , 10 . Volunteers give equipment instruction measure blood sugar home ask keep study diary . Blood pressure , heart rate , laboratory test blood urine , physical examination , report drug side effect ECGs obtain clinic visit assess safety .</brief_summary>
	<brief_title>A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of &gt; / 2000mg Metformin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Diagnosed Type 2 Diabetes least three month prior study Diabetes treat metformin Give consent sign inform consent form . Agree follow specific requirement birth control participation . Type I Diabetes . Treatment insulin within 3 month prior screen History diabetic ketoacidosis lactic acidosis Allergy sensitivity metformin similar drug medical condition prohibit metformin use Excessive blood donation 56 day start study Urinary tract bladder infection within four week study start Alcohol abuse illicit drug use within 12 month study start Receiving investigational drug participate research trial within 30 study start Use prescription nonprescription drug , include vitamin , herbal dietary supplement 714 day study start Live alone without regular , daily interaction someone emergency contact</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Tolerability</keyword>
	<keyword>GSK189075 ,</keyword>
	<keyword>Metformin ,</keyword>
	<keyword>Safety ,</keyword>
	<keyword>Diabetes ,</keyword>
</DOC>